Companies which are more than 50% undervalued based on analyst price target.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
HUBN New	CHF 168.20	-19.9%	57.2%	CHF 3.2b	CHF 261.50	42.7	37.2%	1.2%	Capital Goods
NEAG	CHF 30.30	-1.3%	-12.2%	CHF 1.0b	CHF 60.00	6.6	-14.1%	2.9%	Utilities
CMHC	CHF 58.20	-3.0%	5.2%	CHF 1.0b	CHF 122.09	10.5	55.1%	3.4%	Pharmaceuticals & Biotech
KURN New	CHF 22.46	-2.9%	-19.2%	CHF 896.6m	CHF 33.92	125.6	58.6%	n/a	Pharmaceuticals & Biotech
MEDX	CHF 8.87	-3.0%	-16.9%	CHF 365.9m	CHF 14.97	3610.6	64.6%	1.1%	Healthcare
VETN	CHF 17.32	-6.2%	-42.3%	CHF 343.4m	CHF 28.50	90.4	85.4%	2.9%	Materials
MIKN	CHF 16.10	-3.3%	-14.1%	CHF 271.2m	CHF 29.80	9.6	-1.0%	3.7%	Capital Goods
NWRN	CHF 12.58	-2.8%	61.3%	CHF 269.6m	CHF 47.48	14.7	50.2%	n/a	Pharmaceuticals & Biotech
PEAN	CHF 4.60	-8.1%	-31.4%	CHF 262.6m	CHF 7.87	1.9	104.4%	0%	Real Estate Management and Development
SANN	CHF 16.52	3.3%	15.0%	CHF 258.6m	CHF 27.50	3.3	18.6%	n/a	Pharmaceuticals & Biotech
BIOV	CHF 25.20	-4.9%	0.4%	CHF 147.2m	CHF 58.26	46.6	-14.2%	n/a	Pharmaceuticals & Biotech
VARN	CHF 13.20	-0.8%	-32.3%	CHF 133.7m	CHF 25.18	1.5	7.0%	0%	Real Estate Management and Development
MOLN	CHF 3.49	8.0%	19.9%	CHF 130.5m	CHF 9.00	1.9	16.7%	n/a	Pharmaceuticals & Biotech
LMN	CHF 11.95	-2.8%	-25.3%	CHF 130.5m	CHF 19.37	41.3	60.9%	3.2%	Consumer Services
XLS	CHF 15.10	-1.9%	-28.4%	CHF 87.5m	CHF 31.00	312.8	-6.9%	n/a	Pharmaceuticals & Biotech
MMTX	CHF 0.19	-18.9%	n/a	CHF 31.8m	CHF 2.73	45.1	87.7%	n/a	Pharmaceuticals & Biotech
ASWN	CHF 0.58	-7.9%	-44.8%	CHF 8.5m	CHF 2.00	0.4	74.2%	n/a	Media

Top Stock Picks from Analysts